MedPath

ACTELION PHARMACEUTICALS US, INC.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:3
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

FDA:6

Drug Approvals

OPSYNVI

Approval Date
Apr 2, 2024
FDA

Tracleer

Approval Date
Feb 21, 2024
FDA

Zavesca

Approval Date
Apr 20, 2023
FDA

UPTRAVI

Approval Date
Apr 19, 2023
FDA

Veletri

Approval Date
Nov 28, 2022
FDA

VENTAVIS

Approval Date
Jul 26, 2022
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.